Asia Pacific Knee Cartilage Repair Market
Tamanho do mercado em biliões de dólares
CAGR :
% 
 Período de previsão |
2024 –2030 |
 Tamanho do mercado (ano base ) | |
 Tamanho do mercado ( Ano de previsão) | |
 CAGR |
% |
| Principais participantes do mercado |
>Mercado de reparação da cartilagem do joelho Ásia-Pacífico, por produto (baseado em células e não celular), modalidade (transplante osteocondral, microfratura, artroplastia por abrasão, perfuração, implantação de condrócitos e outros), tipo de cartilagem (cartilagem hialina e fibrocartilagem ), Aplicação (Osteoartrite, Artrite Reumatóide , Esteonecrose, Fraturas, Tumores Ósseos e Outros), Utilizador Final (Hospitais, Blocos Operatórios de Ambulatório, Clínicas Especializadas, Institutos Académicos e de Investigação e Outros), Canal de Distribuição (Vendas Diretas, Distribuidor Terceirizado, Online Vendas e Outros), Tendências do Sector e Previsão para 2030.
Análise e insights do mercado de reparação da cartilagem do joelho da Ásia-Pacífico
Espera-se que os lançamentos de produtos preparem o crescimento das indústrias para aumentar as vendas e a distribuição de reparações da cartilagem do joelho para doenças do joelho. O lançamento do produto irá gerar novas parcerias e colaborações comerciais. O lançamento permitiria aos clientes adquirir o novo produto à sua disposição. Os lançamentos provavelmente retratarão uma tendência positiva no crescimento do mercado.
Além disso, espera-se que o aumento da incidência de doenças do joelho, o aumento da população geriátrica, o aumento da consciencialização sobre o tratamento do joelho na Ásia-Pacífico e os desenvolvimentos tecnológicos nos dispositivos de reparação da cartilagem do joelho impulsionem o crescimento do mercado. As iniciativas estratégicas tomadas pelos principais intervenientes no mercado estão também a impulsionar o crescimento do mercado no período previsto.
No entanto, espera-se que o elevado custo das cirurgias ao joelho e os problemas enfrentados durante a utilização da ortopedia do joelho restrinjam o crescimento do mercado.
A Data Bridge Market Research analisa que o mercado de reparação da cartilagem do joelho da Ásia-Pacífico crescerá a um CAGR de 11,1% durante o período de previsão de 2023 a 2030.
|
Métrica de relatório |
Detalhes |
|
Período de previsão |
2023 a 2030 |
|
Ano base |
2022 |
|
Anos históricos |
2021 (personalizável para 2020-2016) |
|
Unidades Quantitativas |
Receita em milhões de dólares, volumes em unidades, preços em dólares |
|
Segmentos cobertos |
Por produto (baseado em células e não celular), modalidade (transplante osteocondral, microfratura, artroplastia por abrasão, perfuração, implantação de condrócitos e outros), tipo de cartilagem (cartilagem hialina e fibrocartilagem), aplicação (osteoartrite, artrite reumatóide, esteonecrose, Fraturas, Tumores Ósseos e Outros), Utilizador Final (Hospitais, Blocos Operatórios Ambulatório , Clínicas Especializadas, Institutos Académicos e de Investigação e Outros), Canal de Distribuição (Vendas Diretas, Distribuidor Terceirizado, Vendas Online e Outros). |
|
Países abrangidos |
Japão, China, Coreia do Sul, Índia, Austrália, Singapura, Tailândia, Malásia, Indonésia, Filipinas, Vietname e Resto da Ásia-Pacífico. |
|
Participantes do mercado abrangidos |
Stryker, Zimmer Biomet, B. Braun Melsungen AG, Smith & Nephew, BioTissue, CONMED, DePuy Synthes Companies (A part of Johnson & Johnson Medical Devices Companies), Arthrex, Inc., Medacta International, Regrow Biosciences Pvt. Ltd., Regentis Biomaterials Ltd., Anika Therapeutics, Inc., Auxein Medical, BioGend Therapeutics Co., Ltd., CartiHeal, Inc. (A subsidiary of Bioventus Inc.), MEDIPOST, Sartorius CellGenix GmbH, Sanofi and Waldemar Link GmbH & Co. KG, Geistlich Pharma AG, among others |
Market Definition:
The knee is the largest joint in the body. The upper and lower bones of the knee are separated by two discs (menisci). The upper leg bone (femur) and the lower leg bones (tibia and fibula) are connected by ligaments and tendons. Cartilage is the most common type of connective tissue. It is found in various forms throughout our joints, spine, bones, ears, lungs, and nose. Cartilage is a flexible connective tissue that coats the surfaces of the bones in our joints and protects them against impact to maintain joint mobility fluid.
Knee cartilage repair is a procedure that involves repairing damaged cartilage while also smoothing the tissue's remaining surface. Cartilage repair surgery, which attempts to restore cartilage tissue and function to avoid long-term osteoarthritis, is an appropriate treatment choice for focal full-thickness cartilage abnormalities in the knee. Osteotomy, knee replacement, and microfracture are some of the most common knee cartilage repair techniques. The surgical techniques or less prevalent surgical procedures, such as allograft osteochondral transplantation, autologous chondrocyte implantation, and artificial scaffolds, are sometimes utilized to repair cartilage injury.
Asia-Pacific Knee Cartilage Repair Market Dynamics
Drivers
-
INCREASE IN THE PREVALENCE OF KNEE DISORDERS
A perturbação articular mais comum entre os idosos é a osteoartrite do joelho (OA), onde a destruição e perda da cartilagem articular é uma característica central na maioria das formas de artrite, incluindo a forma mais comum que é a osteoartrite. Na osteoartrite, a cartilagem de uma articulação começa a romper e o osso subjacente altera-se. Não só causa dor e incapacidade física aos doentes, como também impõe um fardo de doença significativo para a população como um todo. Anos vividos com incapacidade (YLD) é a métrica padrão para quantificar a carga de doença na maioria das doenças crónicas, como a osteoartrite. Um ano de incapacidade equivale a um ano de vida “saudável” perdida. A soma dos YLD da população, a carga da doença, representa a diferença entre o estado de saúde actual e uma situação de saúde ideal em que toda a população viva até uma idade avançada livre de doenças e incapacidades. Espera-se que o aumento da incidência de doenças crónicas do joelho impulsione as vendas e o fornecimento de medicamentos e implantes para o tratamento dos joelhos na Ásia-Pacífico. Espera-se que vá ao encontro das necessidades do paciente. O conhecimento sobre a prevalência e incidência das doenças ortopédicas do joelho ajudaria a encontrar novas soluções e ajudaria em mais colaborações e parcerias com os participantes do mercado sediados nos países da região Ásia-Pacífico. Assim, espera-se que o aumento dos distúrbios do joelho impulsione o crescimento do mercado.
-
AUMENTO DO NÚMERO DE CIRURGIAS NO JOELHO
As próteses e cirurgias da anca e do joelho são algumas das cirurgias mais frequentemente realizadas e eficazes na Ásia-Pacífico. A osteoartrite é a principal indicação para a artroplastia e cirurgia da anca e do joelho, uma vez que a osteoartrite é também a causa do dano da cartilagem e da destruição da cartilagem articular, pelo que as cirurgias devido à osteoartrite também envolvem a reparação da cartilagem. As cirurgias do joelho estão a tornar-se bastante comuns na Ásia-Pacífico devido à crescente prevalência de lesões do joelho relacionadas com o desporto e à expansão das indicações para a substituição total do joelho devido às preferências do paciente e do cirurgião.
O aumento das cirurgias ao joelho nos países da Ásia-Pacífico garantiria a sensibilização e o tratamento atempados dos doentes com morbilidades crónicas do joelho. O desenvolvimento tecnológico seria de importância crucial no desenvolvimento de implantes avançados do joelho. A otimização adicional e os novos desenvolvimentos tecnológicos abririam o uso de implantes 3D. Espera-se que o aumento do número de cirurgias ao joelho impulsione o crescimento do mercado de reparação da cartilagem do joelho da Ásia-Pacífico.
Oportunidades
-
AUMENTE A CONSCIÊNCIA SOBRE O TRATAMENTO DO JOELHO
Compreender as doenças do joelho e a abrangência do tratamento é vital para ajudar e orientar as pessoas que sofrem de osteoartrite e lesões meniscais. Ajuda a alcançar a deteção e gestão precoces. A sensibilização sobre os sintomas e o tratamento das doenças crónicas do joelho por parte dos institutos públicos e privados resultaria num tratamento atempado e proporcionaria acesso a ajuda de saúde universal e barata, juntamente com uma maior disponibilidade de tratamento de reabilitação. A Asia-Pacific Knee Society (APKS) foi criada para reunir os principais líderes de opinião no campo do joelho degenerativo e da artroplastia do joelho da Ásia-Pacífico e reunir informações valiosas sobre as tendências e a consciencialização crescentes.
A sensibilização para o tratamento precoce e a utilização de implantes do joelho resultaria em colaborações dos players do mercado com as instituições de saúde para o fornecimento e distribuição dos dispositivos. Isto resultará num aumento na expansão de produtos e linhas de negócio. Assim, espera-se que um aumento da consciencialização entre as pessoas sobre o tratamento atempado atue como uma oportunidade para o crescimento do mercado.
-
CRESCENTE POPULAÇÃO GERIÁTRICA
As perturbações do joelho, nomeadamente a osteoartrite do joelho e as roturas ligamentares, são comuns na população idosa na Ásia-Pacífico. Os problemas ósseos afectam provavelmente as pessoas com 60 anos ou mais, especialmente as que residem em instituições de cuidados continuados. À medida que a população idosa envelhece, a prevalência das doenças do joelho pode aumentar, abrindo a porta ao desenvolvimento de medicamentos e implantes em métodos de diagnóstico e prevenção vitais para melhorar as doenças do joelho nas pessoas idosas. Juntamente com outros factores de risco, a vulnerabilidade às doenças do joelho também aumenta com a idade. A osteoartrite do joelho pode ser causada por lesão, infeção ou excesso de peso, ou pode ser herdada em certas pessoas. As mulheres são mais propensas a experimentar o mesmo.
Um tipo de tecido conjuntivo chamado cartilagem pode ser encontrado em todo o corpo. Apesar de ser um material forte e flexível, é relativamente simples de danificar. Além disso, a cartilagem deteriora-se gradualmente com a idade, e quem sofre de osteoartrite apresenta frequentemente rigidez, especialmente após períodos prolongados sentado ou deitado. A capacidade das articulações para suportar as exigências diminui à medida que os amortecedores naturais do corpo se deterioram. Com o avançar da idade, a densidade óssea e o tónus muscular deterioram-se gradualmente, tornando as ocupações fisicamente exigentes ainda mais desafiantes. Portanto, a população idosa em expansão experimenta mais problemas ósseos e articulares que requerem tratamento precoce e, portanto, prevê-se que impulsionem a expansão do mercado.
À medida que a população geriátrica aumenta e o sofrimento crónico do joelho aumenta, isto resultaria num aumento da procura de tratamento. Assim sendo, espera-se que o aumento da população geriátrica impulsione o crescimento do mercado.
Restrições/Desafios
- ALTO CUSTO DE IMPLANTES ORTOPÉDICOS DE JOELHO E CIRURGIAS
Knee arthroplasty is a popular procedure but exhibits a high cost. The cost of knee implants is due to technological development and the rising preference for less invasive orthopedic knee implants.
The cost of Autologous Chondrocyte Implantation (ACI) is expensive. Osteochondral allograft transplantation is a specialized procedure. Its cost is thus high depending upon the cost of the allografts. It ranges from around $10,000. Hence, it is expected to hamper the market growth.
Post-COVID-19 Impact on Asia-Pacific Knee Cartilage Repair Market
COVID-19 has negatively affected the market. Lockdowns and isolation during the pandemic complicate disease management and medication adherence. The lack of access to healthcare facilities for routine treatment and medication administration has impacted the market.
Recent Development
- In March 2022, CritiCare Asia launched Cuvis 3rd Generation Robotic Arm Technology for joint replacement surgeries to enable surgeons to perform complex joint replacement surgeries precisely by overcoming the challenges they face during traditional open surgeries. This way, artificial intelligence aid the surgeries with minimally invasive.
Asia-Pacific Knee Cartilage Repair Market Scope
The Asia-Pacific knee cartilage repair market is categorized into six segments based on product, modality, cartilage type, application, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Cell-Based
- Non-Cell-Based
Based on product, the Asia-Pacific knee cartilage repair market is segmented into cell-based and non-cell-based.
Modality
- Osteochondral Transplantation
- Microfracture
- Abrasion Arthroplasty
- Drilling
- Chondrocyte Implantation
- Others
Based on modality, the Asia-Pacific knee cartilage repair market is segmented into chondrocyte implantation, microfracture, drilling, abrasion arthroplasty, osteochondral transplantation, and others.
Cartilage Type
- Hyaline Cartilage
- Fibrocartilage
Based on cartilage type, the Asia-Pacific knee cartilage repair market is segmented into hyaline cartilage and fibrocartilage.
Application
- Osteoarthritis
- Rheumatoid Arthritis
- Bone Tumors
- Fractures
- Steonecrosis
Based on application, the Asia-Pacific knee cartilage repair market is segmented into osteoarthritis, rheumatoid arthritis, bone tumors, fractures, and steonecrosis.
End User
- Hospital
- Ambulatory Surgical Centers
- Specialty Clinics
- Research And Academic Institutes
- Others
Based on end user, the Asia-Pacific knee cartilage repair market is segmented into hospital, ambulatory surgical centers, specialty clinics, research and academic institutes, and others.
Distribution Channel
- Direct Sales
- Third Party Distributor
- Online Sales
- Others
Based on distribution channel, Asia-Pacific knee cartilage repair market is segmented into direct sales, third party distributor, online sales, and others.
Asia-Pacific Knee Cartilage Repair Regional Analysis/Insights
The Asia-Pacific knee cartilage repair market is analyzed, and market size insights and trends are provided by country, product, modality, cartilage type, application, end user, and distribution channel, as referenced above.
The Asia-Pacific knee cartilage repair market is expected to grow due to an increase in cases of knee disorders and the growing geriatric population. The increasing risk of fractures related to osteoporosis and accident cases is also driving the market growth. In addition, rising initiatives by market players to launch advanced products in the region will further boost market growth in the forecast period.
China is expected to dominate the Asia-Pacific knee cartilage repair market due to advanced technology, the high prevalence of knee osteoarthritis, and an established healthcare system.
The country section of the report also provides individual market-impacting factors and changes in regulations in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of other brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Asia-Pacific Knee Cartilage Repair Market Share Analysis
The Asia-Pacific knee cartilage repair market competitive landscape provides details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, country presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the Asia-Pacific knee cartilage repair market.
Some of the major players operating in the Asia-Pacific knee cartilage repair market are Stryker, Zimmer Biomet, B. Braun Melsungen AG, Smith & Nephew, BioTissue, CONMED, DePuy Synthes Companies (A part of Johnson & Johnson Medical Devices Companies), Arthrex, Inc., Medacta International, Regrow Biosciences Pvt. Ltd., Regentis Biomaterials Ltd., Anika Therapeutics, Inc., Auxein Medical, BioGend Therapeutics Co., Ltd., CartiHeal, Inc. (A subsidiary of Bioventus Inc.), MEDIPOST, Sartorius CellGenix GmbH, Sanofi and Waldemar Link GmbH & Co. KG, Geistlich Pharma AG, among others.
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Índice
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 TREATMENT SEGMENT LIFELINE CURVE
2.8 DBMR MARKET POSITION GRID
2.9 MARKET APPLICATION COVERAGE GRID
2.1 SECONDARY SOURCES
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES MODEL
4.3 PATENT ANALYSIS
5 INDUSTRIAL INSIGHTS
6 EPIDEMIOLOGY
7 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, REGULATION
8 MARKET OVERVIEW
8.1 DRIVERS
8.1.1 INCREASE IN THE PREVALENCE OF KNEE DISORDERS
8.1.2 RISE IN THE NUMBER OF KNEE SURGERIES
8.1.3 GROWTH IN TECHNOLOGICAL ADVANCEMENTS
8.1.4 INCREASE IN DEMAND FOR MINIMALLY INVASIVE PROCEDURES
8.2 RESTRAINTS
8.2.1 HIGH COST OF THE ORTHOPEDIC KNEE IMPLANTS AND SURGERIES
8.2.2 RISE IN CONCERN REGARDING METAL SENSITIVITY IN PATIENTS WITH KNEE IMPLANTS
8.3 OPPORTUNITIES
8.3.1 RISE IN AWARENESS ABOUT KNEE TREATMENT
8.3.2 GROWING GERIATRIC POPULATION
8.3.3 HIGH PREVALENCE OF KNEE INJURIES
8.4 CHALLENGES
8.4.1 LACK OF SKILLED PROFESSIONALS
8.4.2 STRINGENT REGULATIONS
9 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY PRODUCT
9.1 OVERVIEW
9.2 CELL BASED
9.2.1 CHONDROCYTE TRANSPLANTATION
9.2.2 STEM CELL
9.2.3 GROWTH FACTORS
9.3 NON-CELL BASED
9.3.1 TISSUE SCAFFOLDS
9.3.2 CELL-FREE COMPOSITES
10 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY MODALITY
10.1 OVERVIEW
10.2 CHONDROCYTE IMPLANTATION
10.3 MICROFRACTURE
10.4 DRILLING
10.5 ABRASION ARTHROPLASTY
10.6 OSTEOCHONDRAL TRANSPLANTATION
10.7 OTHERS
11 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE
11.1 OVERVIEW
11.2 HYALINE CARTILAGE
11.3 FIBROCARTILAGE
12 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY APPLICATION
12.1 OVERVIEW
12.2 OSTEOARTHRITIS
12.3 RHEUMATOID ARTHRITIS
12.4 FRACTURES
12.5 BONE TUMORS
12.6 OSTEONECROSIS
12.7 OTHERS
13 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY END USER
13.1 OVERVIEW
13.2 HOSPITALS
13.2.1 BY TYPE
13.2.1.1 PRIVATE
13.2.1.2 PUBLIC
13.2.2 BY SIZE
13.2.2.1 LARGE
13.2.2.2 MEDIUM
13.2.2.3 SMALL
13.3 AMBULATORY SURGICAL CENTERS
13.4 SPECIALTY CLINICS
13.5 RESEARCH AND ACADEMIC INSTITUTES
13.6 OTHERS
14 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL
14.1 OVERVIEW
14.2 DIRECT SALES
14.3 THIRD PARTY DISTRIBUTORS
14.4 ONLINE SALES
14.5 OTHERS
15 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY COUNTRY
15.1 CHINA
15.2 JAPAN
15.3 INDIA
15.4 SOUTH KOREA
15.5 AUSTRALIA
15.6 THAILAND
15.7 MALAYSIA
15.8 SINGAPORE
15.9 INDONESIA
15.1 VIETNAM
15.11 PHILIPPINES
15.12 REST OF ASIA-PACIFIC
16 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
17 SWOT ANALYSIS
18 COMPANY PROFILES
18.1 SANOFI
18.1.1 COMPANY SNAPSHOT
18.1.2 REVENUE ANALYSIS
18.1.3 RODUCT PORTFOLIO
18.1.4 RECENT DEVELOPMENT
18.2 ZIMMER BIOMET
18.2.1 COMPANY SNAPSHOT
18.2.2 REVENUE ANALYSIS
18.2.3 PRODUCT PORTFOLIO
18.2.4 RECENT DEVELOPMENTS
18.3 SMITH & NEPHEW
18.3.1 COMPANY SNAPSHOT
18.3.2 REVENUE ANALYSIS
18.3.3 PRODUCT PORTFOLIO
18.3.4 RECENT DEVELOPMENTS
18.4 STRYKER
18.4.1 COMPANY SNAPSHOT
18.4.2 REVENUE ANALYSIS
18.4.3 PRODUCT PORTFOLIO
18.4.4 RECENT DEVELOPMENTS
18.5 MEDIPOST
18.5.1 COMPANY SNAPSHOT
18.5.2 REVENUE ANALYSIS
18.5.3 PRODUCT PORTFOLIO
18.5.4 RECENT DEVELOPMENT
18.6 ARTHREX, INC.
18.6.1 COMPANY SNAPSHOT
18.6.2 PRODUCT PORTFOLIO
18.6.3 RECENT DEVELOPMENT
18.7 ANIKA THERAPEUTICS, INC.
18.7.1 COMPANY SNAPSHOT
18.7.2 REVENUE ANALYSIS
18.7.3 PRODUCT PORTFOLIO
18.7.4 RECENT DEVELOPMENT
18.8 AUXEIN MEDICAL
18.8.1 COMPANY SNAPSHOT
18.8.2 PRODUCT PORTFOLIO
18.8.3 RECENT DEVELOPMENTS
18.9 B. BRAUN MELSUNGEN AG
18.9.1 COMPANY SNAPSHOT
18.9.2 PRODUCT PORTFOLIO
18.9.3 RECENT DEVELOPMENTS
18.1 BIOGEND THERAPEUTICS CO., LTD.
18.10.1 COMPANY SNAPSHOT
18.10.2 PRODUCT PORTFOLIO
18.10.3 RECENT DEVELOPMENTS
18.11 BIOTISSUE
18.11.1 COMPANY SNAPSHOT
18.11.2 PRODUCT PORTFOLIO
18.11.3 RECENT DEVELOPMENT
18.12 CONMED
18.12.1 COMPANY SNAPSHOT
18.12.2 REVENUE ANALYSIS
18.12.3 PRODUCT PORTFOLIO
18.12.4 RECENT DEVELOPMENT
18.13 CARTIHEAL, INC. (A SUBSIDIARY OF BIOVENTUS INC.)
18.13.1 COMPANY SNAPSHOT
18.13.2 REVENUE ANALYSIS
18.13.3 PRODUCT PORTFOLIO
18.13.4 RECENT DEVELOPMENT
18.14 DEPUY SYNTHES COMPANIES (A PART OF JHONSON & JHONSON MEDICAL DEVICES COMPANIES)
18.14.1 COMPANY SNAPSHOT
18.14.2 REVENUE ANALYSIS
18.14.3 PRODUCT PORTFOLIO
18.14.4 RECENT DEVELOPMENT
18.15 GEISTLICH PHARMA AG
18.15.1 COMPANY SNAPSHOT
18.15.2 PRODUCT PORTFOLIO
18.15.3 RECENT DEVELOPMENTS
18.16 MEDACTA INTERNATIONAL
18.16.1 COMPANY SNAPSHOT
18.16.2 PRODUCT PORTFOLIO
18.16.3 RECENT DEVELOPMENT
18.17 REGENTIS BIOMATERIALS LTD.
18.17.1 COMPANY SNAPSHOT
18.17.2 PRODUCT PORTFOLIO
18.17.3 RECENT DEVELOPMENTS
18.18 REGROW BIOSCIENCES PVT LTD.
18.18.1 COMPANY SNAPSHOT
18.18.2 PRODUCT PORTFOLIO
18.18.3 RECENT DEVELOPMENTS
18.19 SARTORIUS CELLGENIX GMBH
18.19.1 COMPANY SNAPSHOT
18.19.2 PRODUCT PORTFOLIO
18.19.3 RECENT DEVELOPMENT
18.2 WALDEMAR LINK GMBH & CO. KG
18.20.1 COMPANY SNAPSHOT
18.20.2 PRODUCT PORTFOLIO
18.20.3 RECENT DEVELOPMENTS
19 QUESTIONNAIRE
20 RELATED REPORTS
Lista de Tabela
TABLE 1 NUMBER OF INDIVIDUALS AFFECTED BY METAL
TABLE 2 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 3 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (UNITS)
TABLE 4 ASIA-PACIFIC CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 5 ASIA-PACIFIC CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 6 ASIA-PACIFIC NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 7 ASIA-PACIFIC NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 8 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 9 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (UNITS)
TABLE 10 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (USD MILLION)
TABLE 11 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (UNITS)
TABLE 12 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 13 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (UNITS)
TABLE 14 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 15 ASIA-PACIFIC HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 16 ASIA-PACIFIC HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2021-2030 (USD MILLION)
TABLE 17 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 18 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 19 CHINA KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 20 CHINA KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (UNITS)
TABLE 21 CHINA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 22 CHINA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 23 CHINA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 24 CHINA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 25 CHINA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 26 CHINA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 27 CHINA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 28 CHINA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (UNITS)
TABLE 29 CHINA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (ASP)
TABLE 30 CHINA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (USD MILLION)
TABLE 31 CHINA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (UNITS)
TABLE 32 CHINA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030, (ASP)
TABLE 33 CHINA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 34 CHINA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (UNITS)
TABLE 35 CHINA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (ASP)
TABLE 36 CHINA KNEE CARTILAGE REPAIR MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 37 CHINA HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 38 CHINA HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2021-2030 (USD MILLION)
TABLE 39 CHINA KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 40 JAPAN KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 41 JAPAN KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (UNITS)
TABLE 42 JAPAN CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 43 JAPAN CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 44 JAPAN CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 45 JAPAN NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 46 JAPAN NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 47 JAPAN NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 48 JAPAN KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 49 JAPAN KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (UNITS)
TABLE 50 JAPAN KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (ASP)
TABLE 51 JAPAN KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (USD MILLION)
TABLE 52 JAPAN KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (UNITS)
TABLE 53 JAPAN KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030, (ASP)
TABLE 54 JAPAN KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 55 JAPAN KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (UNITS)
TABLE 56 JAPAN KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (ASP)
TABLE 57 JAPAN KNEE CARTILAGE REPAIR MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 58 JAPAN HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 59 JAPAN HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2021-2030 (USD MILLION)
TABLE 60 JAPAN KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 61 INDIA KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 62 INDIA KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (UNITS)
TABLE 63 INDIA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 64 INDIA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 65 INDIA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 66 INDIA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 67 INDIA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 68 INDIA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 69 INDIA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 70 INDIA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (UNITS)
TABLE 71 INDIA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (ASP)
TABLE 72 INDIA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (USD MILLION)
TABLE 73 INDIA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (UNITS)
TABLE 74 INDIA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030, (ASP)
TABLE 75 INDIA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 76 INDIA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (UNITS)
TABLE 77 INDIA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (ASP)
TABLE 78 INDIA KNEE CARTILAGE REPAIR MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 79 INDIA HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 80 INDIA HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2021-2030 (USD MILLION)
TABLE 81 INDIA KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 82 SOUTH KOREA KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 83 SOUTH KOREA KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (UNITS)
TABLE 84 SOUTH KOREA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 85 SOUTH KOREA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 86 SOUTH KOREA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 87 SOUTH KOREA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 88 SOUTH KOREA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 89 SOUTH KOREA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 90 SOUTH KOREA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 91 SOUTH KOREA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (UNITS)
TABLE 92 SOUTH KOREA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (ASP)
TABLE 93 SOUTH KOREA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (USD MILLION)
TABLE 94 SOUTH KOREA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (UNITS)
TABLE 95 SOUTH KOREA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030, (ASP)
TABLE 96 SOUTH KOREA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 97 SOUTH KOREA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (UNITS)
TABLE 98 SOUTH KOREA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (ASP)
TABLE 99 SOUTH KOREA KNEE CARTILAGE REPAIR MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 100 SOUTH KOREA HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 101 SOUTH KOREA HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2021-2030 (USD MILLION)
TABLE 102 SOUTH KOREA KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 103 AUSTRALIA KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 104 AUSTRALIA KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (UNITS)
TABLE 105 AUSTRALIA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 106 AUSTRALIA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 107 AUSTRALIA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 108 AUSTRALIA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 109 AUSTRALIA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 110 AUSTRALIA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 111 AUSTRALIA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 112 AUSTRALIA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (UNITS)
TABLE 113 AUSTRALIA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (ASP)
TABLE 114 AUSTRALIA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (USD MILLION)
TABLE 115 AUSTRALIA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (UNITS)
TABLE 116 AUSTRALIA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030, (ASP)
TABLE 117 AUSTRALIA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 118 AUSTRALIA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (UNITS)
TABLE 119 AUSTRALIA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (ASP)
TABLE 120 AUSTRALIA KNEE CARTILAGE REPAIR MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 121 AUSTRALIA HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 122 AUSTRALIA HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2021-2030 (USD MILLION)
TABLE 123 AUSTRALIA KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 124 THAILAND KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 125 THAILAND KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (UNITS)
TABLE 126 THAILAND CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 127 THAILAND CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 128 THAILAND CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 129 THAILAND NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 130 THAILAND NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 131 THAILAND NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 132 THAILAND KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 133 THAILAND KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (UNITS)
TABLE 134 THAILAND KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (ASP)
TABLE 135 THAILAND KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (USD MILLION)
TABLE 136 THAILAND KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (UNITS)
TABLE 137 THAILAND KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030, (ASP)
TABLE 138 THAILAND KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 139 THAILAND KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (UNITS)
TABLE 140 THAILAND KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (ASP)
TABLE 141 THAILAND KNEE CARTILAGE REPAIR MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 142 THAILAND HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 143 THAILAND HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2021-2030 (USD MILLION)
TABLE 144 THAILAND KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 145 MALAYSIA KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 146 MALAYSIA KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (UNITS)
TABLE 147 MALAYSIA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 148 MALAYSIA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 149 MALAYSIA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 150 MALAYSIA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 151 MALAYSIA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 152 MALAYSIA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 153 MALAYSIA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 154 MALAYSIA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (UNITS)
TABLE 155 MALAYSIA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (ASP)
TABLE 156 MALAYSIA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (USD MILLION)
TABLE 157 MALAYSIA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (UNITS)
TABLE 158 MALAYSIA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030, (ASP)
TABLE 159 MALAYSIA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 160 MALAYSIA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (UNITS)
TABLE 161 MALAYSIA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (ASP)
TABLE 162 MALAYSIA KNEE CARTILAGE REPAIR MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 163 MALAYSIA HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 164 MALAYSIA HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2021-2030 (USD MILLION)
TABLE 165 MALAYSIA KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 166 SINGAPORE KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 167 SINGAPORE KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (UNITS)
TABLE 168 SINGAPORE CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 169 SINGAPORE CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 170 SINGAPORE CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 171 SINGAPORE NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 172 SINGAPORE NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 173 SINGAPORE NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 174 SINGAPORE KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 175 SINGAPORE KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (UNITS)
TABLE 176 SINGAPORE KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (ASP)
TABLE 177 SINGAPORE KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (USD MILLION)
TABLE 178 SINGAPORE KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (UNITS)
TABLE 179 SINGAPORE KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030, (ASP)
TABLE 180 SINGAPORE KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 181 SINGAPORE KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (UNITS)
TABLE 182 SINGAPORE KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (ASP)
TABLE 183 SINGAPORE KNEE CARTILAGE REPAIR MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 184 SINGAPORE HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 185 SINGAPORE HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2021-2030 (USD MILLION)
TABLE 186 SINGAPORE KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 187 INDONESIA KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 188 INDONESIA KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (UNITS)
TABLE 189 INDONESIA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 190 INDONESIA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 191 INDONESIA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 192 INDONESIA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 193 INDONESIA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 194 INDONESIA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 195 INDONESIA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 196 INDONESIA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (UNITS)
TABLE 197 INDONESIA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (ASP)
TABLE 198 INDONESIA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (USD MILLION)
TABLE 199 INDONESIA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (UNITS)
TABLE 200 INDONESIA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030, (ASP)
TABLE 201 INDONESIA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 202 INDONESIA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (UNITS)
TABLE 203 INDONESIA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (ASP)
TABLE 204 INDONESIA KNEE CARTILAGE REPAIR MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 205 INDONESIA HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 206 INDONESIA HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2021-2030 (USD MILLION)
TABLE 207 INDONESIA KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 208 VIETNAM KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 209 VIETNAM KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (UNITS)
TABLE 210 VIETNAM CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 211 VIETNAM CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 212 VIETNAM CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 213 VIETNAM NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 214 VIETNAM NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 215 VIETNAM NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 216 VIETNAM KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 217 VIETNAM KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (UNITS)
TABLE 218 VIETNAM KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (ASP)
TABLE 219 VIETNAM KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (USD MILLION)
TABLE 220 VIETNAM KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (UNITS)
TABLE 221 VIETNAM KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030, (ASP)
TABLE 222 VIETNAM KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 223 VIETNAM KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (UNITS)
TABLE 224 VIETNAM KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (ASP)
TABLE 225 VIETNAM KNEE CARTILAGE REPAIR MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 226 VIETNAM HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 227 VIETNAM HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2021-2030 (USD MILLION)
TABLE 228 VIETNAM KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 229 PHILIPPINES KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 230 PHILIPPINES KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (UNITS)
TABLE 231 PHILIPPINES CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 232 PHILIPPINES CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 233 PHILIPPINES CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 234 PHILIPPINES NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 235 PHILIPPINES NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 236 PHILIPPINES NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 237 PHILIPPINES KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 238 PHILIPPINES KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (UNITS)
TABLE 239 PHILIPPINES KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (ASP)
TABLE 240 PHILIPPINES KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (USD MILLION)
TABLE 241 PHILIPPINES KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (UNITS)
TABLE 242 PHILIPPINES KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030, (ASP)
TABLE 243 PHILIPPINES KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 244 PHILIPPINES KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (UNITS)
TABLE 245 PHILIPPINES KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (ASP)
TABLE 246 PHILIPPINES KNEE CARTILAGE REPAIR MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 247 PHILIPPINES HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 248 PHILIPPINES HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2021-2030 (USD MILLION)
TABLE 249 PHILIPPINES KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 250 REST OF ASIA PACIFIC KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 251 REST OF ASIA PACIFIC KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (UNITS)
Lista de Figura
FIGURE 1 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: SEGMENTATION
FIGURE 2 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: DBMR POSITION GRID
FIGURE 8 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: APPLICATION COVERAGE GRID
FIGURE 9 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: SEGMENTATION
FIGURE 10 INCREASE IN THE PREVALENCE OF KNEE DISORDERS AND A RISE IN THE NUMBER OF KNEE SURGERIES ARE EXPECTED TO DRIVE ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET
FIGURE 11 CELL-BASED SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET FROM 2023 & 2030
FIGURE 12 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET
FIGURE 13 NUMBER OF TOTAL KNEE ARTHROPLASTIES FROM 2011-2019 IN CHINA
FIGURE 14 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY PRODUCT, 2022
FIGURE 15 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 16 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 17 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 18 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY MODALITY, 2022
FIGURE 19 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY MODALITY, 2023-2030 (USD MILLION)
FIGURE 20 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY MODALITY, CAGR (2023-2030)
FIGURE 21 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY MODALITY, LIFELINE CURVE
FIGURE 22 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY CARTILAGE TYPE, 2022
FIGURE 23 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY CARTILAGE TYPE, 2023-2030 (USD MILLION)
FIGURE 24 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY CARTILAGE TYPE, CAGR (2023-2030)
FIGURE 25 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY CARTILAGE TYPE, LIFELINE CURVE
FIGURE 26 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY APPLICATION, 2022
FIGURE 27 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 28 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 29 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 30 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY END USER, 2022
FIGURE 31 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 32 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY END USER, CAGR (2023-2030)
FIGURE 33 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY END USER, LIFELINE CURVE
FIGURE 34 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 35 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 36 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 37 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 38 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: SNAPSHOT (2022)
FIGURE 39 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY COUNTRY (2022)
FIGURE 40 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY COUNTRY (2023 & 2030)
FIGURE 41 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY COUNTRY (2022 & 2030)
FIGURE 42 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY PRODUCT (2023-2030)
FIGURE 43 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: COMPANY SHARE 2022 (%)
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.
